Reaction Details Report a problem with these data
Target
Galectin-3
Ligand
BDBM50077225
Substrate
n/a
Meas. Tech.
ChEMBL_2250692 (CHEMBL5164902)
Kd
49000±n/a nM
Citation
 Bum-Erdene, K; Collins, PM; Hugo, MW; Tarighat, SS; Fei, F; Kishor, C; Leffler, H; Nilsson, UJ; Groffen, J; Grice, ID; Heisterkamp, N; Blanchard, H Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia. J Med Chem 65:5975-5989 (2022) [PubMed] 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM50077225
Synonyms:
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]thio}tetrahydro-2H-pyran-3,4,5-triol | CHEMBL52011 | THIODIGALACTOSIDE
Type:
Small organic molecule
Emp. Form.:
C12H22O10S
Mol. Mass.:
358.362
SMILES:
OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O |r|
Structure:
Search PDB for entries with ligand similarity: